Aberdeen Group
SNY icon

Aberdeen Group’s Sanofi SNY Stock Holding History

Aberdeen Group’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1M Buy
471,254
+13,333
+3% +$596K 0.03% 446
2026
Q1 		$22.1M Sell
457,921
-9,320
-2% -$435K 0.04% 400
2025
Q4 		$22.6M Buy
467,241
+86,314
+23% +$4.28M 0.04% 387
2025
Q3 		$18M Buy
380,927
+57,345
+18% +$2.77M 0.03% 466
2025
Q2 		$15.6M Buy
323,582
+127,534
+65% +$6.52M 0.03% 482
2025
Q1 		$10.9M Sell
196,048
-118,132
-38% -$6.39M 0.02% 540
2024
Q4 		$15.2M Buy
314,180
+64,095
+26% +$3.26M 0.03% 425
2024
Q3 		$14.4M Sell
250,085
-109,348
-30% -$5.9M 0.03% 450
2024
Q2 		$17.4M Buy
359,433
+141,688
+65% +$6.83M 0.03% 406
2024
Q1 		$10.6M Buy
217,745
+59,100
+37% +$2.89M 0.02% 540
2023
Q4 		$7.89M Buy
+158,645
New +$7.76M 0.02% 592

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Aberdeen Group's SNY Position: Q2 2026 in Review

Aberdeen Group increased its Sanofi (SNY) stake by 2.9% in Q2 2026, buying an estimated $596K and bringing the position to 471,254 shares worth $20.1M. The position accounts for 0.03% of the portfolio, ranked #446.

Aberdeen Group first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $22.6M in Q4 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Aberdeen Group held 471,254 shares of Sanofi worth $20.1M as of Q2 2026.
  • Aberdeen Group bought 13,333 Sanofi shares in Q2 2026, an estimated $596K.
  • Sanofi made up 0.03% of Aberdeen Group's portfolio in Q2 2026, its #446 holding.
  • Aberdeen Group first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
  • Aberdeen Group's Sanofi position peaked at $22.6M in Q4 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.